Osel Devices Limited Obtains FDA Registration for Hearing Aid Manufacturing Facility
New Delhi, April 01, 2026 – Osel Devices Limited announced today that its hearing aid manufacturing facility in Greater Noida, Uttar Pradesh, India, has been registered with the United States Food and Drug Administration (FDA).The registration was confirmed by the U.S. Department of Health and Human Services through the FDA's Center for Devices and Radiological Health (CDRH), and the facility is now listed in the FDA Registration and Device Listing Database.
Strategic Significance and Business Impact
This development is expected to have a significant impact on Osel Devices Limited’s operations. The company anticipates entering the U.S. medical devices market, one of the largest globally, and unlocking substantial revenue potential.According to the company, the registration is expected to enhance export capabilities and accelerate growth in the hearing aid segment. Access to regulated markets like the U.S. is anticipated to positively impact operating margins through superior pricing.
The achievement is also expected to strengthen the company's brand equity and competitive standing in international markets. Osel Devices Limited is currently exploring strategic partnerships, original equipment manufacturing (OEM) opportunities, and distribution alliances in the U.S. and other developed markets, aligning with the company's export-led growth strategy.
Source:
Disclaimer: Due care and diligence have been taken in compiling and presenting news and market-related content. However, errors or omissions may arise despite such efforts.
The information provided is for general informational purposes only and does not constitute investment advice, a recommendation, or an offer to buy or sell any securities. Readers are advised to rely on their own assessment and judgment and consult appropriate financial advisers, if required, before taking any investment-related decisions.